About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Detroit | 7,240 Studies Near You

Clinical TrialsDetroit

Clinical Trials in Detroit

Discover 7,240 clinical trials near Detroit, Michigan. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2841-2860 of 7,240 trials

RecruitingGemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic CancerThe goal of this study is to learn if the combination of nab-paclitaxel, gemcitabine and an Amplitude-Modulated Radiofrequency Electromagnetic Fields device (Therabionic P1) is…NCT06576115·Clarkston, Michigan and 6 others CompletedA Study of Mood and Stress After Spinal Cord InjuryThis is a study of factors, such as pain, family support, psychological history and alcohol/substance use, that may influence whether a person experiences depression after their…NCT01337908·San Jose, California and 3 others CompletedCombination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00003389·Mobile, Alabama and 538 others

Find Trials by Condition in Detroit

Breast Cancerin Detroit Lung Cancerin Detroit Prostate Cancerin Detroit Colorectal Cancerin Detroit Melanomain Detroit Leukemiain Detroit Lymphomain Detroit Pancreatic Cancerin Detroit Ovarian Cancerin Detroit Brain Cancerin Detroit Diabetes

Data from ClinicalTrials.govTerms

CompletedGet With the Guidelines in ED Patients With Heart FailureApproximately 20-30% of patients presenting with acute heart failure are discharged from the ED.NCT02519283·Atlanta, Georgia and 14 others

TerminatedRosuvastatin in African Americans With Cerebrovascular DiseaseThis study will assess the rate at which rosuvastatin will achieve LDL targets in African American patients with previous history of stroke or TIA.NCT01975194·Detroit, Michigan

UnknownFinding Acute Coronary Syndromes (ACS) With Serial Troponin Testing for Rapid Assessment of Cardiac Ischemic SymptomsStudy Objectives The following items will be prospectively assessed. Primary Endpoints 1.NCT00880802·Davis, California and 15 others

TerminatedA Study of LY3039478 in Participants With Advanced or Metastatic Solid TumorsThe main purpose of this study is to evaluate the safety of the study drug known as LY3039478 in combination with other anticancer agents in participants with advanced or…NCT02784795·Miami, Florida and 10 others

RecruitingA Study of Alisertib in Patients With Extensive Stage Small Cell Lung CancerPUMA-ALI-4201 is a Phase 2 study evaluating alisertib monotherapy in patients with pathologically-confirmed small cell lung cancer (SCLC) following progression on or after…NCT06095505·Daphne, Alabama and 29 others

RecruitingA Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2This study is being done to see if a drug called disitamab vedotin, alone or with pembrolizumab, works to treat HER2 expressing urothelial cancer.NCT04879329·Gilbert, Arizona and 220 others

CompletedStudy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic StrokeControlled study of stereotactic, intracranial injection of SB623 cells in patients with fixed motor deficits from ischemic strokeNCT02448641·Birmingham, Alabama and 64 others

CompletedEvaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MSThe purpose of this study is to evaluate the safety and tolerability of IV administration of VX15/2503 in patients with multiple sclerosis.NCT01764737·Cullman, Alabama and 9 others

CompletedNeurophysiological Maturation Correlate With Clinical MilestonesTo examine the association of early measures of heart rate variability and amplitude-integrated electroencephalography with time to wean to crib and to achieve full oral feeds…NCT03722901·Detroit, Michigan and 1 other

CompletedGM-CSF for Immunomodulation Following Trauma (GIFT) StudyThe GIFT study is a prospective, multi-center, interventional trial using the drug GM-CSF for the reversal of innate immune suppression in critically injured children.NCT01495637·Aurora, Colorado and 7 others

CompletedDetecting Infections Rapidly and Easily for Candidemia Trial (DIRECT)The purpose of this study is to assure the uniform collection, handling, storage and transport of patient whole blood specimens and associated information to support validation of…NCT01525095·Birmingham, Alabama and 4 others

CompletedA Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)The purpose of this study is to characterize the safety, tolerability, and efficacy of topical SM04554 solution (0.15% and 0.25%) applied to the scalp of male subjects with…NCT02275351·Encinitas, California and 23 others

CompletedDocetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of breast cancer cells, either by killing the cells or by stopping them from dividing.NCT01547741·Anchorage, Alaska and 914 others

CompletedANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based TreatmentThis randomized, open-label, multicenter study will evaluate the safety , efficacy and tolerability of the combination treatment RO5466731, RO5190591, ritonavir and Copegus…NCT01628094·La Jolla, California and 30 others

CompletedEffects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44The core study assessed the efficacy of a higher dose of rivastigmine 13.3 mg/24 h transdermally (15 cm\^2 patch) compared to a lower dose of the rivastigmine 4.6 mg/24 h…NCT00948766·Tempe, Arizona and 94 others

Active not recruitingCarboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube CancerThis randomized phase III trial studies carboplatin, paclitaxel and gemcitabine hydrochloride when given together with or without bevacizumab after surgery to see how well it…NCT00565851·Anchorage, Alaska and 708 others

CompletedS0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone TherapyRATIONALE: Drugs used in chemotherapy, such as docetaxel, prednisone, and atrasentan work in different ways to stop the growth of tumor cells, either by killing the cells or by…NCT00134056·Mobile, Alabama and 553 others

PreviousPage 143 of 362Next

in Detroit

Heart Diseasein Detroit